Biogen Reports Top-Line Results from Phase 2 Study of Opicinumab (Anti-LINGO-1) in Multiple Sclerosis
http://media.biogen.com/press-release/i ... anti-lingo
Biogen Opicinumab(Anti-LINGO-1) Fails Phase 2 Study of in MS
-
- Similar Topics
- Replies
- Views
- Last post
-
- 0 Replies
- 12357 Views
-
Last post by NHE
-
- 0 Replies
- 2363 Views
-
Last post by frodo
-
- 0 Replies
- 1399 Views
-
Last post by Petr75
-
- 0 Replies
- 10683 Views
-
Last post by NHE
-
- 0 Replies
- 1971 Views
-
Last post by NHE
-
- 0 Replies
- 2485 Views
-
Last post by frodo
-
- 0 Replies
- 1584 Views
-
Last post by frodo
-
- 0 Replies
- 1520 Views
-
Last post by frodo
-
- 0 Replies
- 1230 Views
-
Last post by frodo